Involve primary-care doctor in retinal artery occlusion
February 1st 2010Referral to a primary-care physician is a critical component in the care of patients with a retinal artery occlusion because the ophthalmic event usually is a manifestation of a systemic disease, which by itself is associated with increased morbidity and mortality, according to experts.
Ocular olopatadine administration provides adjuvant effects on allergic nasal symptoms
February 1st 2010Analyses of data from two hybrid environmental studies evaluating 0.2% olopatadine HCl ophthalmic solution QD for the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis show that patients derive improvement in the frequency or severity of their nasal symptoms as a simultaneous benefit with relief of ocular allergy.
Topical corticosteroid offers effective intervention
February 1st 2010For patients who suffer with moderate to severe signs and symptoms of seasonal or perennial allergic conjunctivitis, loteprednol etabonate 0.2% is a safe and well-tolerated therapeutic option that can provide rapid clinical improvement, according to an expert.
Review key concepts in glaucoma evaluation, management
January 1st 2010Some critical issues to consider when diagnosing glaucoma are the recognition of an association between sleep dysfunction and glaucoma, the effect of corneal thickness on the accuracy of intraocular pressure (IOP) measurements, and the importance of first determining optic disk size when evaluating cup-to-disc ratio.
Removing benzalkonium chloride may not reduce irritation
January 1st 2010Switching to another prostaglandin analogue that does not contain benzalkonium chloride may not be the answer for managing patients complaining of dryness and irritation while using latanoprost 0.005%, according to the results of a prospective, double-masked, randomized clinical study by eye-care professionals at Lackland Air Force Base.